Trials / Completed
CompletedNCT04401280
Bioactive Glass in the Treatment of Enamel White Spot Lesions
Effectiveness of Novel Bioactive Glass in the Treatment of Enamel White Spot Lesions : A Randomized Controlled Trial
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Rania Salah · Academic / Other
- Sex
- All
- Age
- 14 Years – 26 Years
- Healthy volunteers
- Accepted
Summary
the aim of this study is to evaluate the effectiveness of BiominF® and Novamin® in comparison to Casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) in the treatment of enamel white spot lesions
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BiominF | in office application of bioactive glass followed by self administered application by the patient until a point of white spot remineralization is reached |
| DRUG | Novamin | in office application of bioactive glass followed by self administered application by the patient until a point of white spot remineralization is reached |
| DRUG | CPP-ACP | applied in accordance with the manufacturer's specifications |
Timeline
- Start date
- 2020-06-01
- Primary completion
- 2021-06-30
- Completion
- 2021-06-30
- First posted
- 2020-05-26
- Last updated
- 2021-10-19
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04401280. Inclusion in this directory is not an endorsement.